MYLAN 7025 MYLAN 7025 (Loxapine Succinate 25 mg)

Pill with imprint MYLAN 7025 MYLAN 7025 is Green / Brown, Capsule-shape and has been identified as Loxapine Succinate 25 mg. It is supplied by Mylan Pharmaceuticals Inc..

Loxapine is used in the treatment of agitated state; schizophrenia; agitation and belongs to the drug class miscellaneous antipsychotic agents. FDA has not classified the drug for risk during pregnancy. Loxapine 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 7025 MYLAN 7025

Loxapine Succinate

Imprint:

MYLAN 7025 MYLAN 7025

Strength:

25 mg

Color:

Green / Brown

Size:

18.00 mm

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Miscellaneous antipsychotic agents

Pregnancy Category:

N - Not classified

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Mylan Pharmaceuticals Inc.

Inactive Ingredients:

• lactose anhydrous
• silicon dioxide
• croscarmellose sodium
• magnesium stearate
• sodium lauryl sulfate
• magnesium silicate
• ferrosoferric oxide
• FD&C Blue No. 1
• titanium dioxide
• ferric oxide yellow
• D&C Yellow No. 10
• FD&C Green No. 3
• FD&C Blue No. 2
• FD&C Red No. 40
• propylene glycol
• shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC Code	Labeler / Repackager
00378-7025	Mylan Pharmaceuticals Inc.
51079-0902	UDL Laboratories Inc.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer